Propanc Biopharma, Inc.
PPCB$84M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBERWELL, VICTORIA1 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 5, 2026
6wMarket Overview
Stock performance and key metrics
PPCB News
Catalyst Timeline
1 upcoming, 0 past
How PPCB's past catalysts played out
Drug Pipeline
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Propanc Biopharma, Inc.'s next FDA catalyst?→
Propanc Biopharma, Inc.'s (PPCB) next tracked catalyst is a Earnings expected October 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PPCB biotech catalysts?→
Add PPCB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Propanc Biopharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply